C12N 2770/24271
Demonstrated in vivo effect
C12N2770/24271 (Demonstrated in vivo effect) appears on 15 US grants and 23 published applications in this corpus.
Search patents in C12N- Granted patents
- 15
- Published applications
- 23
- Assignees
- 16
- Inventors
- 47
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 1 |
| 2015 | 0 | 4 |
| 2016 | 1 | 1 |
| 2017 | 6 | 3 |
| 2018 | 1 | 2 |
| 2019 | 1 | 0 |
| 2020 | 1 | 2 |
| 2021 | 1 | 0 |
| 2022 | 1 | 3 |
| 2023 | 0 | 1 |
| 2024 | 1 | 1 |
| 2025 | 1 | 2 |
| 2026 | 1 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Immunogenic compositions of hepatitis c virus and uses thereof14 Apr 2026US 12,599,661 B2
- Regulatable cell surface receptors and related compositions and methods28 Oct 2025US 12,454,562 B2The Board of Trustees of the Leland Stanford Junior University
- Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling2 Jul 2024US 12,023,375 B2University of Washington
- Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling10 May 2022US 11,324,817 B2University of Washington through its Center for Commercialization
- Senecavirus a immunogenic compositions and methods thereof23 Nov 2021US 11,179,457 B2
- Zika and hcv attenuated viruses and use thereof2 Jul 2026US 2026/0185060 A1Bar-Ilan University
- Regulatable Cell Surface Receptors and Related Compositions and Methods19 Mar 2026US 2026/0078164 A1The Board of Trustees of the Leland Stanford Junior University
- Self-cleaving polyproteins and uses thereof6 Nov 2025US 2025/0339512 A1The University of Melbourne
- Anti-viral peptide compositions and methods to improve biological activity thereof11 Sep 2025US 2025/0282830 A1Nanyang Technological University
- Immunogenic compositions of hepatitis c virus and uses thereof13 Jun 2024US 2024/0189421 A1
Most cited
By later US patents
- HCV full-length infectious cell culture systems and applications thereof5US 9,382,517 B2Hvidovre Hospital · 2016
- Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling2US 10,434,164 B2University of Washington through its Center for Commercialization · 2019
- Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling2US 9,775,894 B2University of Washington through its Center for Commercialization · 2017
- Senecavirus a immunogenic compositions and methods thereof1US 11,179,457 B22021
- Attenuated recombinant vesicular stomatitis viruses comprising modified mutant matrix proteins1US 9,630,996 B22017